Public and private partnerships between the United States and Japan have helped both countries bring new drugs, vaccines, and other life-saving medical advancements to the global market. Last May, U.S. and Japanese government officials signaled their mutual desire to "promote collaboration among drug discovery start-ups of both countries."
Just last week, Japanese Prime Minister Fumio Kishida reiterated how "increasingly important" it is that Japan and the United States collaborate on biotechnology during his visit to Washington, DC.
Continued collaboration between our two nations can bring more revolutionary treatments to patients in need. As venture capital continues to flow in both countries, it is critical for the U.S. and Japan to take steps that ease uncertainty and promote investment. Together, we can make the next decade of innovation the most successful yet.
